Susquehanna International Group
DRNA

Susquehanna International Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Susquehanna International Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-111,005
Closed -$2.24M – 14377
2021
Q3 		$2.24M Sell
111,005
-41,688
-27% -$1.15M ﹤0.01% 5588
2021
Q2 		$5.7M Buy
152,693
+108,476
+245% +$3.32M ﹤0.01% 3803
2021
Q1 		$1.13M Sell
44,217
-18,220
-29% -$465K ﹤0.01% 7403
2020
Q4 		$1.38M Sell
62,437
-131,270
-68% -$2.89M ﹤0.01% 5944
2020
Q3 		$3.48M Buy
193,707
+171,848
+786% +$3.56M ﹤0.01% 3616
2020
Q2 		$555K Sell
21,859
-4,300
-16% -$92.6K ﹤0.01% 7156
2020
Q1 		$481K Buy
+26,159
New +$508K ﹤0.01% 7025
2019
Q4 		– Sell
-26,862
Closed -$541K – 11013
2019
Q3 		$386K Sell
26,862
-9,318
-26% -$133K ﹤0.01% 7816
2019
Q2 		$570K Buy
+36,180
New +$492K ﹤0.01% 7014
2018
Q2 		– Sell
-86,291
Closed -$1.08M – 10722
2018
Q1 		$825K Sell
86,291
-13,083
-13% -$141K ﹤0.01% 5655
2017
Q4 		$897K Buy
+99,374
New +$731K ﹤0.01% 5457
2016
Q3 		– Sell
-11,130
Closed -$33K – 9283
2016
Q2 		$33K Buy
+11,130
New +$45.7K ﹤0.01% 8310

Other funds holding DRNA

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Susquehanna International Group's DRNA Position: Q4 2021 in Review

Susquehanna International Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 111,005 shares — an estimated $2.24M sold.

Susquehanna International Group first reported a position in DRNA in Q2 2016 and held it in 12 quarters. The position peaked at $5.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

  • Susquehanna International Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Susquehanna International Group sold 111,005 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2.24M.
  • Susquehanna International Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2016 and held it in 12 quarters.
  • Susquehanna International Group's Dicerna Pharmaceuticals, Inc. position peaked at $5.7M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.